<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04326842</url>
  </required_header>
  <id_info>
    <org_study_id>HZHZS1</org_study_id>
    <nct_id>NCT04326842</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography Angiography Evaluation of Ocular Changes in Patients With Carotid Artery Stenosis</brief_title>
  <official_title>Optical Coherence Tomography Angiography Evaluation of Ocular Changes in Patients With Carotid Artery Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Harbin Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate ocular changes in patients with carotid artery stenosis by
      optical coherence tomography angiography before and after carotid artery revascularization
      procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A growing body of research indicates that abnormal ocular microvascular features may serve as
      a novel biomarker reflecting the severity of underlying cardiovascular, neurodegenerative,
      and microvascular disease. Since blood flow to the retina is predominantly supplied by the
      internal carotid artery (ICA), we hypothesized that ocular microvasculature and structure
      changes may reflect the disease status or therapeutic effects in patients with carotid artery
      stenosis.

      Optical coherence tomography angiography (OCTA) is a novel, non-invasive imaging modality
      that can be a reliable tool for the qualitative and quantitative assessments of ocular
      vessels during various ocular pathological or physiological changes. Recent studies have also
      demonstrated the ability of OCTA to quantify retinal microvascular changes in monitoring
      cardiovascular risk.

      This study aims to evaluate ocular changes in patients with carotid artery stenosis by
      optical coherence tomography angiography before and after carotid artery revascularization
      procedure.In this study, the patients with carotid artery stenosis and control group will
      receive a series of cerebral and ocular examinations including the most important cerebral CT
      perfusion (CTP) and OCTA. After that, the cerebral and ocular data between the two groups
      will be compared. Also, the preoperative and postoperative data acquired will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vessel density</measure>
    <time_frame>Difference of vessel density in each group at baseline</time_frame>
    <description>Vessel density of OCTA examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vessel density</measure>
    <time_frame>Changes at 4 days after carotid artery procedure</time_frame>
    <description>Vessel density of OCTA examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vessel density</measure>
    <time_frame>Changes at 3 months after carotid artery procedure</time_frame>
    <description>Vessel density of OCTA examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vessel density</measure>
    <time_frame>Changes at 1 year after carotid artery procedure</time_frame>
    <description>Vessel density of OCTA examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ocular structural parameters</measure>
    <time_frame>Difference of ocular structural parameters in each group at baseline</time_frame>
    <description>Ocular structural parameters of OCTA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ocular structural parameters</measure>
    <time_frame>Changes at 4 days after carotid artery procedure</time_frame>
    <description>Ocular structural parameters of OCTA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ocular structural parameters</measure>
    <time_frame>Changes at 3 months after carotid artery procedure</time_frame>
    <description>Ocular structural parameters of OCTA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ocular structural parameters</measure>
    <time_frame>Changes at 1 year after carotid artery procedure</time_frame>
    <description>Ocular structural parameters of OCTA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral perfusion</measure>
    <time_frame>Difference of cerebral perfusion in each group at baseline</time_frame>
    <description>CTP will be used to detect cerebral perfusion in carotid artery stenosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral perfusion</measure>
    <time_frame>Changes at 4 days after carotid artery procedure</time_frame>
    <description>CTP will be used to detect cerebral perfusion in carotid artery stenosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral perfusion</measure>
    <time_frame>Changes at 3 months after carotid artery procedure</time_frame>
    <description>CTP will be used to detect cerebral perfusion in carotid artery stenosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral perfusion</measure>
    <time_frame>Changes at 1 year after carotid artery procedure</time_frame>
    <description>CTP will be used to detect cerebral perfusion in carotid artery stenosis</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Carotid Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>Carotid artery stenosis</arm_group_label>
    <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Patients without carotid artery stenosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Carotid artery revascularization procedure</intervention_name>
    <description>The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.</description>
    <arm_group_label>Carotid artery stenosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical coherence tomography angiography</intervention_name>
    <description>Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
    <arm_group_label>Carotid artery stenosis</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants with carotid artery stenosis undergoing cerebral and eye examination and in
        routine clinical practice will be included
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of carotid artery stenosis

          -  Age-gender-race-matched controls

        Exclusion Criteria:

          -  Unable to complete cerebral CTP or OCTA examination

          -  Severe corneal leukoplakia, cataract, retinal disease, strabismus, nystagmus and other
             reasons leading to low OCTA image quality (quality&lt;6)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Zhang</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Harbin Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Huaizhang Shi</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Harbin Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sujun Zhou</last_name>
    <phone>+86 18704616237</phone>
    <email>2315186458@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hong Zhang</last_name>
    <phone>+86 13804505456</phone>
    <email>13804505456@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sujun Zhou</last_name>
      <email>2315186458@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 24, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2020</study_first_posted>
  <last_update_submitted>April 10, 2020</last_update_submitted>
  <last_update_submitted_qc>April 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Carotid Artery Stenosis</keyword>
  <keyword>OCTA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>July 6, 2020</submitted>
    <returned>July 22, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

